St. James Investment Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
St. James Investment Company's NVS Position: Q3 2016 in Review
St. James Investment Company sold out of Novartis (NVS) in Q3 2016, closing a stake of 10,288 shares — an estimated $761K sold.
St. James Investment Company first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $52.2M in Q1 2014. 878 funds tracked by Wall St. Rank hold NVS as of Q3 2016.
- St. James Investment Company reported no remaining Novartis position as of Q3 2016 after selling out during the quarter.
- St. James Investment Company sold 10,288 Novartis shares in Q3 2016, an estimated $761K.
- St. James Investment Company first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
- St. James Investment Company's Novartis position peaked at $52.2M in Q1 2014.
- 878 funds tracked by Wall St. Rank held Novartis as of Q3 2016.
Based on St. James Investment Company's 13F filing for Q3 2016, filed 1 Nov 2016.